Background illustration for clinical trials search

Paid Clinical Trials Worcester

Discover 3,097 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, New York NY, Hackensack NJ,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Boston MA, Hartford CT, The Bronx NY, Syracuse NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase1, Recruiting

Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

for
Stenosis of Trachea
Location: Boston MA
Sponsor: Beth Israel Deaconess Medical Center

Sex: All

Age: 0+

Code: NCT06761170

Phase2, Recruiting

Neonatal Platelet Transfusion Threshold Trial

for
Thrombocytopenia, Neonatal, Platelet Transfusion,
Location: Boston MA, Philadelphia PA, Rochester NY, Cleveland OH,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT06676904

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

for
Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer,
Location: Boston MA
Sponsor: Jacqueline Garcia, MD

Sex: All

Age: 18+

Code: NCT07148180

Phase1, Phase2, Recruiting

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

for
Vascular Access Device
Location: Boston MA, Huntsville AL, Loma Linda CA
Sponsor: Teleflex

Sex: All

Age: 0+

Code: NCT06604039

Recruiting

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

for
Persistent Atrial Fibrillation
Location: Boston MA, Fall River MA, Lebanon NH, Manhasset NY,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT06735534

Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for
Schizophrenia
Location: Boston MA, The Bronx NY, New York NY, Cedarhurst NY,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase3, Recruiting

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

for
Mantle Cell Lymphoma, Lymphoma
Location: Boston MA, New York NY, St Louis MO
Sponsor: Christine Ryan

Sex: All

Age: 18+

Code: NCT06854003

Phase2, Recruiting

Accelerated TMS for Perinatal Depression

for
Perinatal Depression, Post Partum Depression,
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: Female

Age: 18 - 55

Code: NCT06968390

Recruiting

CUE-102 in Recurrent Glioblastoma

for
Recurrent Glioblastoma, Glioblastoma, Glioma, Malignant
Location: Boston MA
Sponsor: David Reardon, MD

Sex: All

Age: 18+

Code: NCT06917885

Phase1, Recruiting

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

for
Endometrial Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT03675893

Phase2, Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, New York NY, Philadelphia PA, Madison WI,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 18+

Code: NCT06844383

Phase2, Recruiting

Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS

for
Unstable Blood Pressure, Hypotension
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0

Code: NCT06994494

Recruiting

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

for
Prostate Cancer (Adenocarcinoma), Prostate Specific Antigen
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Male

Age: 18+

Code: NCT06862856

Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Harrison NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase2, Recruiting

Sacituzumab Govitecan Plus EV in Metastatic UC

for
Urothelial Cancer, Metastatic Urothelial Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04724018

Phase1, Phase2, Recruiting

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

for
Renal Cell Carcinoma, Urothelial Carcinoma,
Location: Boston MA, Philadelphia PA, Cleveland OH, Ann Arbor MI,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06966024

Phase1, Recruiting

Behavioral Intervention for Youth to Promote Vaping Cessation

for
Vaping, Vaping Teens, Nicotine Dependence
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 14 - 19

Code: NCT06765291

Recruiting